Shanghai Pharmaceuticals Holding Co Ltd banner

Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 17.16 CNY -0.29% Market Closed
Market Cap: ¥63.6B

Balance Sheet

Balance Sheet Decomposition
Shanghai Pharmaceuticals Holding Co Ltd

Balance Sheet
Shanghai Pharmaceuticals Holding Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
537
672
512
430
314
629
629
1 037
4 887
6 511
14 850
13 525
12 979
11 609
12 039
11 967
14 842
18 694
18 083
22 227
2 072
27 238
27 500
31 881
Cash
0
0
0
0
0
0
0
0
0
0
0
8
8
8
9
8
11
6
6
8
5
24 534
27 500
31 881
Cash Equivalents
537
672
512
430
314
629
629
1 037
4 887
6 511
14 850
13 517
12 971
11 601
12 030
11 959
14 831
18 688
18 077
22 219
2 067
2 705
0
0
Short-Term Investments
51
3
43
92
116
20
36
9
10
4
3
3
0
1
1
4
1
5
3
1
0
9 614
11 197
10 373
Total Receivables
1 512
1 856
2 381
2 829
2 345
2 319
2 405
2 745
5 766
8 628
12 219
14 379
17 443
22 519
26 383
30 162
34 454
46 642
52 234
57 719
63 759
73 225
81 948
86 539
Accounts Receivables
1 147
1 451
1 590
1 963
1 699
2 033
2 214
2 620
4 849
6 999
10 606
12 604
15 184
19 941
24 215
27 293
31 377
42 152
47 340
52 746
58 108
66 760
72 934
79 129
Other Receivables
365
405
791
866
646
286
191
125
917
1 629
1 613
1 775
2 259
2 578
2 168
2 869
3 077
4 490
4 894
4 973
5 651
6 465
9 014
7 409
Inventory
824
1 170
1 358
1 223
1 351
1 364
1 364
1 623
3 701
5 233
8 297
9 810
10 997
13 088
15 091
16 416
17 270
25 024
24 877
24 088
27 104
34 460
36 623
38 944
Other Current Assets
70
67
94
175
216
260
346
108
272
1 662
626
1 085
1 097
1 443
2 071
1 719
2 075
2 912
2 894
3 528
3 427
4 975
5 166
4 087
Total Current Assets
2 994
3 768
4 388
4 751
4 342
4 591
4 781
5 523
14 637
22 038
35 996
38 802
42 515
48 658
55 585
60 267
68 642
93 278
98 092
107 563
116 494
149 513
162 434
171 823
PP&E Net
698
1 057
1 077
1 033
945
1 370
1 130
914
3 946
4 249
4 040
4 260
4 810
4 994
6 091
6 966
9 100
10 604
13 128
14 626
16 128
16 542
18 279
19 305
PP&E Gross
698
1 057
1 077
1 033
945
1 370
1 130
914
3 946
0
4 040
4 260
4 810
4 994
6 091
6 966
9 100
10 604
13 128
14 626
16 128
16 542
18 279
19 305
Accumulated Depreciation
245
314
374
303
267
441
426
425
2 365
0
3 058
3 416
3 732
3 753
3 920
4 187
4 643
5 267
7 481
8 820
9 760
10 773
11 969
13 013
Intangible Assets
184
195
186
147
74
541
526
447
839
897
1 276
1 407
1 540
1 862
1 984
2 767
2 702
4 283
4 142
5 419
6 309
6 587
6 361
5 833
Goodwill
0
0
0
0
0
0
0
0
100
423
2 989
3 173
3 643
4 473
4 816
5 848
6 607
11 345
10 790
11 342
11 239
11 336
11 393
11 146
Note Receivable
0
0
0
0
0
50
50
50
93
50
0
0
119
253
333
425
581
316
266
170
198
212
228
386
Long-Term Investments
369
333
448
461
962
312
589
748
2 034
2 219
3 022
3 007
3 144
3 229
4 249
4 826
5 125
4 954
5 725
7 898
11 049
11 724
10 917
10 201
Other Long-Term Assets
38
48
44
48
18
64
50
75
226
289
345
420
541
872
1 286
1 644
1 586
2 098
4 885
2 167
2 018
2 221
2 360
2 516
Other Assets
0
0
0
0
0
0
0
0
100
423
2 989
3 173
3 643
4 473
4 816
5 848
6 607
11 345
10 790
11 342
11 239
11 336
11 393
11 146
Total Assets
4 283
N/A
5 403
+26%
6 143
+14%
6 440
+5%
6 342
-2%
6 929
+9%
7 126
+3%
7 756
+9%
21 875
+182%
30 163
+38%
47 668
+58%
51 069
+7%
56 312
+10%
64 341
+14%
74 344
+16%
82 743
+11%
94 344
+14%
126 879
+34%
137 026
+8%
149 186
+9%
163 436
+10%
198 135
+21%
211 973
+7%
221 209
+4%
Liabilities
Accounts Payable
941
1 314
1 462
1 567
1 343
1 957
2 337
2 617
4 795
7 006
10 564
12 144
14 153
17 150
20 674
22 307
23 346
30 975
31 819
32 861
37 231
45 604
47 915
50 242
Accrued Liabilities
191
254
316
276
195
346
272
410
1 339
1 942
349
553
639
710
773
1 017
1 222
1 187
1 561
1 348
1 656
2 588
10 950
10 895
Short-Term Debt
1 156
1 574
1 956
2 313
2 618
2 486
2 352
2 398
4 219
7 194
7 771
7 331
8 621
11 218
14 152
13 306
17 695
23 514
28 192
30 014
36 289
39 715
51 572
55 281
Current Portion of Long-Term Debt
0
0
14
0
0
0
0
0
48
28
1
1
26
21
290
5
6
2 007
1 186
8 885
578
3 229
2 963
841
Other Current Liabilities
126
127
153
117
83
182
165
156
643
796
2 172
2 069
2 260
2 903
3 537
4 478
7 363
11 028
11 850
15 024
16 070
19 555
8 972
8 780
Total Current Liabilities
2 413
3 269
3 901
4 273
4 238
4 970
5 127
5 582
11 044
16 966
20 856
22 098
25 699
32 003
39 427
41 113
49 632
68 710
74 608
88 133
91 824
110 691
122 372
126 038
Long-Term Debt
17
31
90
102
103
3
3
25
84
0
0
2
125
107
94
2 864
2 982
9 638
10 290
2 685
8 592
7 561
7 336
9 728
Deferred Income Tax
0
0
0
0
0
3
3
1
33
44
266
282
289
380
392
492
620
867
810
832
999
1 049
1 016
816
Minority Interest
313
440
398
298
248
350
317
401
2 153
2 819
2 903
3 062
3 047
3 277
3 878
5 212
5 645
7 420
7 727
9 386
9 707
10 939
11 802
12 067
Other Liabilities
44
40
43
28
23
30
35
58
278
326
564
985
1 198
752
623
1 439
1 434
1 231
1 933
2 794
2 954
831
923
885
Total Liabilities
2 788
N/A
3 780
+36%
4 431
+17%
4 701
+6%
4 613
-2%
5 356
+16%
5 484
+2%
6 066
+11%
13 593
+124%
20 154
+48%
24 589
+22%
26 430
+7%
30 358
+15%
36 518
+20%
44 414
+22%
51 120
+15%
60 314
+18%
87 866
+46%
95 367
+9%
103 831
+9%
114 076
+10%
131 072
+15%
143 448
+9%
149 534
+4%
Equity
Common Stock
316
316
474
474
474
474
569
569
569
1 993
2 689
2 689
2 689
2 689
2 689
2 689
2 689
2 842
2 842
2 842
2 842
3 698
3 703
3 708
Retained Earnings
370
495
567
592
577
428
490
542
2 753
4 175
5 910
7 520
9 081
10 968
13 060
15 354
17 900
20 819
23 639
26 880
30 591
34 639
36 129
38 854
Additional Paid In Capital
809
812
671
672
679
665
579
578
4 954
3 846
14 490
14 446
14 204
14 152
14 146
13 558
13 507
15 845
15 721
15 898
16 071
29 098
29 188
29 648
Unrealized Security Profit/Loss
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18
27
42
Other Equity
0
0
0
0
0
6
3
1
6
5
10
16
19
13
35
21
65
493
542
265
144
390
469
492
Total Equity
1 495
N/A
1 623
+9%
1 712
+5%
1 739
+2%
1 728
-1%
1 573
-9%
1 641
+4%
1 689
+3%
8 282
+390%
10 010
+21%
23 078
+131%
24 639
+7%
25 954
+5%
27 822
+7%
29 930
+8%
31 623
+6%
34 031
+8%
39 014
+15%
41 659
+7%
45 355
+9%
49 359
+9%
67 063
+36%
68 524
+2%
71 676
+5%
Total Liabilities & Equity
4 283
N/A
5 403
+26%
6 143
+14%
6 440
+5%
6 342
-2%
6 929
+9%
7 126
+3%
7 756
+9%
21 875
+182%
30 163
+38%
47 668
+58%
51 069
+7%
56 312
+10%
64 341
+14%
74 344
+16%
82 743
+11%
94 344
+14%
126 879
+34%
137 026
+8%
149 186
+9%
163 436
+10%
198 135
+21%
211 973
+7%
221 209
+4%
Shares Outstanding
Common Shares Outstanding
569
569
569
569
569
569
569
569
569
1 993
2 689
2 689
2 689
2 689
2 689
2 689
2 689
2 842
2 842
2 842
2 842
3 698
3 703
3 708